Boc-Cys(SEt)-OH · DCHA is a Boc-protected cysteine derivative bearing an S-ethyl (SEt) thioether side chain, where the amino acid backbone contains a carbamate-protected α-amino group and a free α-carboxylic acid for peptide chemistry. The molecule features a thioether-functionalized side chain on the cysteine residue and is presented as a DCHA salt, which modulates the counterion environment while the Boc group serves to suppress undesired amine reactivity during stepwise coupling. In synthesis and chemical biology workflows, this protected amino acid is used as a building block for incorporating a cysteine-like residue with an ethylated sulfur side chain into peptides and related amino acid derivatives, supporting controlled chemoselectivity in the assembly of sulfur-containing sequences and conjugation-ready intermediates.
Boc-Cys(SEt)-OH · DCHA is a Boc-protected cysteine derivative bearing an SEt (ethylthio) side-chain functionality, supplied as a dicyclohexylamine (DCHA) salt to improve handling and crystallinity for synthesis workflows. The combination of an N-terminal Boc group and a thioether-protected thiol provides a controlled reactivity profile that is commonly leveraged in peptide assembly and thiol-manipulation strategies, where the side-chain sulfur can be selectively transformed downstream. This reagent is routinely selected by peptide chemists and process developers who require cysteine chemistry without premature thiol interference during coupling and deprotection steps.
1. Solid-Phase Peptide Synthesis
Boc-Cys(SEt)-OH · DCHA is used as a cysteine building block for peptide synthesis workflows where the N-terminus is protected as Boc and the side-chain sulfur is masked as an ethylthio group. In solid-phase peptide synthesis, peptide manufacturers and academic peptide groups rely on this protection pattern to minimize undesired side reactions from free thiols during repeated coupling cycles, while still enabling cysteine-containing sequences that may later require thiol reactivity for disulfide formation or selective conjugation. The DCHA salt form supports practical reagent handling in automated or semi-automated peptide synthesis, helping maintain consistent coupling performance across batches.
2. Disulfide and Thiol-Directed Chemistry
Boc-Cys(SEt)-OH · DCHA is frequently chosen as a cysteine precursor for downstream thiol-directed transformations after peptide assembly, particularly when the target workflow requires controlled access to sulfur chemistry. Thioether-protected cysteine residues enable staged conversion to reactive thiol species under conditions compatible with the rest of the peptide or conjugate, supporting workflows such as disulfide bond formation, thiol-maleimide coupling, or other sulfur-reactive labeling strategies used in peptide and protein engineering. Researchers developing cysteine-rich peptides, cyclic peptides, or redox-stabilized constructs often select this derivative to reduce side reactions during assembly while preserving a defined point of sulfur activation later in the process.
3. Peptide Conjugation Building Blocks
Boc-Cys(SEt)-OH · DCHA serves as a practical intermediate for preparing peptide conjugation handles where cysteine functionality is required at a specific position within a peptide scaffold. Chemical biology groups and custom peptide synthesis providers use this reagent to incorporate cysteine residues that can be converted to thiol-reactive forms post-synthesis, enabling attachment of peptides to linkers, affinity tags, polymers, or biomolecule carriers through thiol-based coupling chemistries. The protected thiol strategy helps maintain peptide integrity during synthesis and purification, while the masked side-chain sulfur supports a controlled "activation later" workflow that is especially valuable when conjugation conditions must be decoupled from peptide assembly.
4. Pharmaceutical Intermediate Development
Boc-Cys(SEt)-OH · DCHA is also used in the development of cysteine-containing pharmaceutical intermediates and advanced synthetic building blocks where sulfur reactivity must be managed across multi-step sequences. Process chemists and medicinal chemistry groups incorporate this derivative as a protected cysteine unit to build intermediates that later undergo sulfur functionalization under controlled conditions, supporting the preparation of sulfhydryl-bearing motifs embedded in larger fragments. The Boc/DCHA-SEt protection strategy aligns with industrially relevant workflows that require stable intermediates during isolation and handling, while still providing a defined route to downstream thiol or sulfur-functional derivatives.
1. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
5. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.